Kappa Bioscience extends research partnership and funds first human clinical trial to explore vitamin K2 implication in COVID-19 Kappa Bioscience announces a new agreement with Canisius Wilhelmina Hospital, Nijmegen, The Netherlands, covering funding of a PhD grant and execution of a clinical trial. This first-ever human clinical trial exploring the potential benefits of vitamin K2.
The post Kappa Bioscience extends research and funds first human clinical trial to explore vitamin K2 implication in COVID-19 appeared first on Nutraceuticals Now.
Nutraceuticals Now – Read More